UC Davis conducts clinical trials on antibody cocktail President Trump took during COVID-19 treatment

We’re learning more about the experimental drug that the president received as part of his COVID-19 treatment. UC Davis is conducting trials on the antibody cocktail as a treatment and preventative method. Watch the video above to hear from one of the lead researchers about the promise he believes this drug offers.